- Trial Guidance Positively Updated -
DUBLIN, Ireland and MYSTIC, Conn., Aug. 10
/PRNewswire-FirstCall/ -- Amarin Corporation plc (NASDAQ:AMRN)
, a clinical-stage biopharmaceutical company with a focus on
cardiovascular disease, today announced...
...